DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c77ce3/generic_and_innova) has announced the addition of the "Generic and Innovative Drugs Market in Central Europe 2011" report to their offering.
Generic and innovative drug market in CE countries 2011: Comparative analysis, reimbursement policies and development forecasts for 2011-2013
Generic and innovative drug market in CE countries 2011 is a unique new report that provides a detailed illustration of the current market conditions in Central Europe, both as one cohesive region and in the individual marketplaces of: Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria.
In addition to the latest analysis of key effects of recent economic difficulties in these markets, this timely document provides comparative analysis, news on reimbursement policies and the development forecasts for 2011-2013 needed for success in this quickly changing industry.
The expert analysts at PMR Publications have closely examined the issues that affect market conditions and require skillful navigation within todays CE generic and innovative drug market:
- prices
- reimbursement policies
- insurers, exclusivity of data regulations
- formula patent time periods
- expiration dates
- counterfeit medicines.
They have carefully compiled their research, analysis and projections to create a single concise and cost-effective document that saves readers time and money by offering the widest scope of necessary coverage without sacrificing any of the required detail.
The report presents a sharply-focused view of the future by predicting changes in market size and share for the coming two years, as well as in-depth treatment of current and future reimbursement lists and processes and their impact on the market. It examines VAT rates, and outlines expected changes in data exclusivity periods allotted to innovative medicine companies.
Readers will gain an insightful understanding of the behaviour and reasoning of market participants through detailed description of:
- the preferences of the consumer, medical patient and prescribing physician concerning generics and innovative drugs
- company profiles that spotlight the activities and achievements of the largest developers, manufacturers and distributors of the many products that are classified in this specific portion of the regions pharmaceutical market.
Key Topics Covered:
I. Report methodology
II. Executive summary
III. Characteristics of generic and innovative drug markets in Central European countries
- Comparative analysis
- - Prices of generic and innovative drugs
- - Market value between 2008 and 2013
- - Average CAGR for generic and innovative drug markets in CE countries 2011-2013
- - Market share of generic and innovative medicines
- - Main trends and events on generic and innovative drug market
- - Market size
- - Share of pharmaceutical market
- - Market forecasts for 2011-2013
- - IV. Best-selling drugs in Central Europe
- - Best-selling drugs
- - Drug patent expiry and data exclusivity periods
- Comparative analysis of drug patent expiry and data exclusivity periods in CE
V. Counterfeit products
VI. Reimbursement and pricing policies in Central Europe
- Pricing policies
- VAT rate
- Non-reimbursed drugs on pharmacy market
- Reimbursed drugs on pharmacy market
- Drugs on hospital market
- Reimbursement policies
- Reimbursement system
- Reimbursement process
- Reimbursement spending
- Reimbursement reform
- Latest changes to reimbursement lists
- Expected changes to reimbursement lists
VII. Key manufacturers
- Profiles of selected leading generic drug manufacturers in CE
- Profiles of selected leading innovative drug manufacturers in CE
- Key players in selected CE countries
For more information visit http://www.researchandmarkets.com/research/c77ce3/generic_and_innova